News and Announcements
Analytica (ASX: ALT) Annual Update 2015; Receives 510(k) Clearance with FDA & Raises $2.9m
- Published December 16, 2015 4:05PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
In 2015, Analytica (ASX:ALT) achieved a critical regulatory milestone receiving 510(k) clearance with the US FDA for the PeriCoach, which along with Australian and European approval, allows the company to sell the product globally. Analytica also undertook a rights issue which raised $2.9 million. The company increased its US sales and marketing efforts with a distribution agreement with Currently Technology Inc and a partnership with SalesForce4Hire. Analytica has an exciting year ahead as it drives towards a licensing deal, identifies new market and commercialization opportunities for PeriCoach and accelerates research and development efforts to make further enhancements to the product.
ABOUT ANALYTICA
Analytica Ltd (ASX: ALT) is an Australian medical device manufacturing and commercialisation company. Its lead product, the PeriCoach System, is a novel medical device to treat stress urinary incontinence (SUI) – a condition with significant unmet medical need and huge market potential.
PeriCoach is a medical device that measures the muscles that matter when treating stress urinary incontinence and increases pelvic muscle strength. The device is low-risk with low manufacturing cost and readily scalable production. Analytica already has regulatory approval in US, Europe and Australia with sales underway.
Company Updates
BlackRock has named the next Economy. What this latest paper means for Private Market Investors.
BlackRock has put a name on something the smart money has been circling for two years. Its digital assets research team calls it the machine-native economy. The thesis fits in one line. AI is machine-native intelligence. Digital assets are machine-native money. Both are built on the same architecture, and they are converging into a single […]
Where’s the beef? Blackstone just answered the AI question.
In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation
For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]
Backed By Leading Investment Groups and Family Offices
